Research study Program year 2021 Source: CMS Open Payments

A Phase 2 Exploratory Study of Intravenous Quzyttir (Cetirizine HCl Injection) Versus IV Diphenhydramine in the Prevention of Hypersesitivity Infusion Reactions

Research payments

$299,054

41 payments

Through program year 2021, $299,054 in research payments was reported against A Phase 2 Exploratory Study of Intravenous Quzyttir (Cetirizine HCl Injection) Versus IV Diphenhydramine in the Prevention of Hypersesitivity Infusion Reactions, across 41 payments, paid by TerSera Therapeutics LLC.

Paid by: TerSera Therapeutics LLC
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2021	Research	$149,917	14
2020	Research	$149,137	27

Breakdown

Who paid Research payments · program years 2020–2021

TerSera Therapeutics LLC $299,054 41 payments

Who received the money Research payments · program years 2020–2021

Oncology Consultants Organisation paid for research $110,801 3 payments
Eisenhower Medical Center Teaching hospital · CA $53,961 13 payments
St Joseph Health - Santa Rosa Organisation paid for research $44,725 7 payments
Baylor Scott & White Organisation paid for research $29,140 5 payments
St Joseph Health - Napa Organisation paid for research $19,338 3 payments
Scott And White Memorial Hospital Teaching hospital · TX $17,633 4 payments
St. Joseph Heritage Health - Napa Organisation paid for research $13,456 4 payments
Dent Neurologic Institute Organisation paid for research $10,000 2 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

5 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.